← Prestige Consumer Healthcare Inc. PBH
Market Price
$51.40
Market Cap
$2.43B
P/E Ratio
13.15
Revenue (FY 2026)
↓-4.3% YoY
$1.09B
3-Yr CAGR: -1.2%
Net Income
↓-11.3% YoY
$190.30M
Net Margin: 17.5%
Free Cash Flow
↑1.3% YoY
$246.45M
FCF Yield: 10.14%
EPS (Diluted)
↓-8.9% YoY
$3.91
Basic: $3.93
Return on Equity
Efficiency
10.1%
ROA: 1,148.9%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (PBH)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $882.1M | — | $500.3M | $69.4M | — | $1.30 | — | $147.8M | $144.8M | — |
| FY 2018 | $1,041.2M | +18.0% | $576.5M | $339.6M | +389.3% | $6.34 | +387.7% | $210.1M | $197.6M | +36.5% |
| FY 2019 | $975.8M | -6.3% | $555.6M | $-35.8M | -110.5% | $-0.69 | -110.9% | $189.3M | $178.8M | -9.5% |
| FY 2020 | $963.0M | -1.3% | $552.2M | $142.3M | +497.4% | $2.78 | +502.9% | $217.1M | $202.6M | +13.3% |
| FY 2021 | $943.4M | -2.0% | $547.5M | $164.7M | +15.7% | $3.25 | +16.9% | $235.6M | $213.4M | +5.3% |
| FY 2022 | $1,086.8M | +15.2% | $620.6M | $205.4M | +24.7% | $4.04 | +24.3% | $259.9M | $250.3M | +17.3% |
| FY 2023 | $1,127.7M | +3.8% | $625.3M | $-82.3M | -140.1% | $-1.65 | -140.8% | $229.7M | $221.9M | -11.3% |
| FY 2024 | $1,125.4M | -0.2% | $624.4M | $209.3M | +354.3% | $4.17 | +352.7% | $248.9M | $239.4M | +7.9% |
| FY 2025 | $1,137.8M | +1.1% | $634.5M | $214.6M | +2.5% | $4.29 | +2.9% | $251.5M | $243.3M | +1.6% |
| FY 2026 | $1,088.7M | -4.3% | $595.6M | $190.3M | -11.3% | $3.91 | -8.9% | $257.6M | $246.4M | +1.3% |
Valuation
Market Price
$51.40
Market Cap
$2.43B
Enterprise Value
N/A
P/E Ratio
13.15
P/B Ratio
1.29
FCF Yield
10.14%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
54.71%
Operating Margin
28.42%
Net Margin
17.48%
Return on Equity (ROE)
10.08%
Return on Assets (ROA)
1,148.88%
Asset Turnover
65.73x
Revenue 3-Yr CAGR
-1.17%
Financial Health & Liquidity
Current Ratio
0.14
Cash Ratio
0.53
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$63.87M
Total Debt
N/A
Book Value / Share
$39.84
Cash Flow Efficiency
Operating Cash Flow
$257.63M
Capital Expenditures (CapEx)
$11.18M
Free Cash Flow
$246.45M
OCF / Revenue
23.66%
FCF / Revenue
22.64%
FCF 3-Yr CAGR
3.55%
Per Share Metrics
EPS (Diluted)
$3.91
EPS (Basic)
$3.93
Dividends / Share
N/A
Book Value / Share
$39.84
EPS YoY Growth
-8.86%
Balance Sheet (FY 2026)
Total Assets
$16.56M
Total Liabilities
$120.92M
Stockholders' Equity
$1.89B
Current Assets
$16.56M
Current Liabilities
$120.92M